Tianeptine, initially developed as the mood-boosting drug in the 1980s, has generated considerable discussion internationally. Unlike common antidepressants which act by boosting serotonin levels, tianeptine suggests to promote serotonin reuptake and affects glutamate , leading atypical effects . Its accessibility through unregulated channels , oft